NeuroPace, Inc. (NPCE) reported a second-quarter 2024 loss of 26 cents per share compared with the year-ago quarter's reported loss of 36 cents. The figure was also narrower than the Zacks Consensus Estimate of a loss of 29 cents per share. Q2 Revenues Revenues totaled $19.3 million, up 16.9% year over year. The figure topped the Zacks Consensus Estimate by 2.9%. The revenue growth was driven by increased sales of the RNS System. Margins The gross profit in the reported quarter was $14.1 million, up 18.1% y ...